Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166361 · ClinicalTrials.gov registry record · NA
Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00166361: Completed NA study, sponsored by Mayo Clinic.
NCT00166361 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00166361, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the Memokath 051 ureteral stent as a long-term temporary and minimally invasive means of providing ureteral drainage in the setting of malignant extrinsic ureteral obstruction secondary to inoperable abdominal or pelvic malignancies. Up to 15 adults who have extrinsic ureteral obstruction secondary to an inoperable abdominal or pelvic malignancy and need ureteral stent drainage will undergo outpatient placement of the ureteral stent. Ongoing monitoring will continue for as long as the stent is in place.
Interventions
- DEVICE Memokath 051 Ureteral Stent
- DEVICE JJ Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2004-02 |
| Est. Completion | 2008-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166361
The ClinicalTrials.gov registry entry for NCT00166361 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Memokath 051 Ureteral Stent is the first listed.
NCT00166361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166361 about?
NCT00166361 is a clinical study titled "Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent". The purpose of this study is to evaluate the safety and efficacy of the Memokath 051 ureteral stent as a long-term temporary and minimally invasive means of providing ureteral drainage in the setting of malignant extrinsic ureteral obstruction secondary to inoperable abdominal or pelvic malignancies...
What is the current status of trial NCT00166361?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2004-02. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00166361?
The interventions under investigation include: Memokath 051 Ureteral Stent (DEVICE), JJ Stent (DEVICE).
Who is sponsoring clinical trial NCT00166361?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.